Deferred Tax Assets, Valuation Allowance of Galera Therapeutics, Inc. from 31 Dec 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Galera Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2018 to 31 Dec 2024.
  • Galera Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $75,754,000, a 4% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Galera Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $75,754,000 +$2,893,000 +4% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $72,861,000 +$14,437,000 +25% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $58,424,000 +$5,637,000 +11% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $52,787,000 +$4,478,000 +9.3% 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q4 2020 $48,309,000 +$16,247,000 +51% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q4 2019 $32,062,000 +$10,154,000 +46% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q4 2018 $21,908,000 31 Dec 2018 10-K 10 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.